UNH - UnitedHealth Group Incorporated
| Previous close | 259.77 |
| Open | 262.60 |
| Bid | 0.00 x 800 |
| Ask | 0.00 x 800 |
| Day's range | 260.42 - 266.26 |
| 52-week range | 208.48 - 287.94 |
| Volume | 4,844,751 |
| Avg. volume | 4,107,693 |
| Market cap | 255.42B |
| Beta (3Y monthly) | 1.06 |
| PE ratio (TTM) | 20.83 |
| EPS (TTM) | 12.74 |
| Earnings date | 15 Apr 2019 - 22 Apr 2019 |
| Forward dividend & yield | 3.60 (1.39%) |
| Ex-dividend date | 2018-11-30 |
| 1y target est | 305.61 |
- Zacks•18 hours ago
Top Ranked Value Stocks to Buy for January 21st
Top Ranked Value Stocks to Buy for January 21st
- Zacks•4 days ago
Dow 30 Stock Roundup: JPM & AXP Earnings Disappoint, GS & UNH Impress
The index enjoyed another strong week of gains, increasing over three straight sessions.
- Zacks•5 days ago
Is UnitedHealth Group (UNH) Outperforming Other Medical Stocks This Year?
Is (UNH) Outperforming Other Medical Stocks This Year?
- Zacks•5 days ago
Top Ranked Value Stocks to Buy for January 17th
Top Ranked Value Stocks to Buy for January 17th
- GlobeNewswire•5 days ago
Analysis: Positioning to Benefit within Motorola Solutions, FibroGen, UnitedHealth Group, Newell Brands, Vuzix, and Choice Hotels International — Research Highlights Growth, Revenue, and Consolidated Results
NEW YORK, Jan. 17, 2019 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
- Zacks•6 days ago
UnitedHealth Gains on Strong 4Q Results, 2019 Looks Favorable
UnitedHealth (UNH) shares gained following a strong fourth-quarter results, operating fundamentals point to a solid 2019
- Zacks•6 days ago
UnitedHealth Pops on Solid Q4: Healthcare ETFs to Buy
ETFs having the largest allocation to UnitedHealth has been in focus post its solid result.
- Zacks•6 days ago
Stock Market News For Jan 16, 2019
Benchmarks ended in the green on Tuesday as Netflix buoyed gains for the broader markets.
Motley Fool•6 days agoUnitedHealth Group (UNH) Q4 2018 Earnings Conference Call Transcript
UNH earnings call for the period ending December 31, 2018.
- Associated Press•6 days ago
Netflix, UnitedHealth and Edwards climb; Wells Fargo dips
Stocks that moved substantially or traded heavily Tuesday: Netflix Inc., up $21.70 to $354.64 The video streaming company said it will raise prices for its U.S. subscribers. Microsoft Corp., up $2.96 to ...
- Motley Fool•6 days ago
What Happened in the Stock Market Today
Stocks bounced back despite an earnings miss by JPMorgan Chase. Meanwhile, UnitedHealth Group beat expectations on strong growth.
- Investor's Business Daily•6 days ago
UnitedHealth Earnings Top Estimates
UnitedHealth Group, the nation's largest insurer, reported earnings before the open on Tuesday that exceeded Wall Street expectations. UnitedHealth stock rose in early trade, giving a lift to Dow Jones futures.
- Barrons.com•7 days ago
UnitedHealth Stock Is Higher After Earnings Beat
Leerink’s Ana Gupte reiterated an Outperform rating on the stock and a $335 price target following the report. She writes that UnitedHealth turned in a “solid top- and bottom-line beat.”
- Zacks•7 days ago
The Earnings Story So Far & What To Watch During Q4 Report Season
Ryan McQueeney recaps Netflix's subscription price hike and earnings results from Delta, UnitedHealth, Wells Fargo, and JPMorgan. Later, he chats with Dave Bartosiak about bank earnings and how investors can profit throughout the Q4 report season.
Associated Press•7 days agoUnitedHealth shares climb after 4Q earnings beat
UnitedHealth's fourth-quarter earnings slid 16 percent from last year, when a federal tax overhaul helped the nation's largest health insurer, but the performance still came in well above analyst expectations. Optum runs a large pharmacy benefit management business and a growing number of clinics and urgent care and surgery centers. UnitedHealth's insurance side, which generates more revenue but thinner profits, had flat operating earnings of $1.8 billion.
- Zacks•7 days ago
PPI Joins Q4 Reports for JPM, WFC & More; Big Day for Data
Currently, Q4 earnings season is heating up in earnest, with two top Wall Street banks and two other sector leaders bringing results ahead of the opening bell.
- Investor's Business Daily•7 days ago
Tech Stocks Advance With These 2 Dow Jones Stocks Mixed On Earnings
The tech-heavy Nasdaq composite led the way early Tuesday. Dow Jones stocks JPMorgan and UnitedHealth reported earnings results.
- Investor's Business Daily•7 days ago
Stocks Climb Ahead Of Brexit: Dow Jones Lags, Netflix Spikes
JPMorgan sagged, but Delta Air, Edwards Lifesciences and Netflix were early leaders as stocks rose ahead of the UK's critical Brexit vote.
Motley Fool•7 days agoUnitedHealth Finishes 2018 on a Healthy Note
Here's why the health insurer's optimistic about 2019.
- Zacks•7 days ago
UnitedHealth (UNH) Beats on 4Q Earnings, Keeps 2019 Guidance
UnitedHealth's (UNH) fourth-quarter results gain from higher revenues and membership.
- Zacks•7 days ago
UnitedHealth Group (UNH) Surpasses Q4 Earnings and Revenue Estimates
UnitedHealth (UNH) delivered earnings and revenue surprises of 2.50% and 0.83%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
- Market Realist•7 days ago
UnitedHealth Group’s Performance in Fiscal 2018
UnitedHealth Group Releases Stellar Fiscal 2018 ResultsPerformance in fiscal 2018 In UnitedHealth Group’s (UNH) fourth-quarter earnings release, the company announced its fiscal 2018 revenues of $226.2 billion—a rise of 12% YoY
- Zacks•8 days ago
A Look at Dow ETF Ahead of Q4 Earnings
Let's delve into the Q4 earnings picture that will likely set up the movement of Dow Jones ETF in the coming days.
- GlobeNewswire•8 days ago
Valeritas Announces V-Go® Received Preferred Status on OptumRx Formularies
Valeritas Holdings, Inc. (VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, a simple, all-in-one, wearable insulin delivery option for patients with diabetes, today announced that V-Go is Preferred on the OptumRx formulary. “We are very excited that V-Go is now Preferred on OptumRx formularies,” said Valeritas CEO, John Timberlake. “V-Go helps patients simplify their insulin therapy and improve their management of diabetes.
